| 000 | 01672 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514041254.0 | ||
| 264 | 0 | _c20020809 | |
| 008 | 200208s 0 0 eng d | ||
| 022 | _a1524-4628 | ||
| 024 | 7 |
_a10.1161/01.str.0000023534.37670.f7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDijkhuizen, Rick M | |
| 245 | 0 | 0 |
_aRapid breakdown of microvascular barriers and subsequent hemorrhagic transformation after delayed recombinant tissue plasminogen activator treatment in a rat embolic stroke model. _h[electronic resource] |
| 260 |
_bStroke _cAug 2002 |
||
| 300 |
_a2100-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBrain _xblood supply |
| 650 | 0 | 4 |
_aCerebral Hemorrhage _xetiology |
| 650 | 0 | 4 | _aContrast Media |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFerrosoferric Oxide |
| 650 | 0 | 4 |
_aInfarction, Middle Cerebral Artery _xcomplications |
| 650 | 0 | 4 | _aIron |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMicrocirculation _xdrug effects |
| 650 | 0 | 4 | _aOxides |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred SHR |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xadministration & dosage |
| 700 | 1 | _aAsahi, Minoru | |
| 700 | 1 | _aWu, Ona | |
| 700 | 1 | _aRosen, Bruce R | |
| 700 | 1 | _aLo, Eng H | |
| 773 | 0 |
_tStroke _gvol. 33 _gno. 8 _gp. 2100-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.str.0000023534.37670.f7 _zAvailable from publisher's website |
| 999 |
_c12041158 _d12041158 |
||